A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...

The Aerospace Corporation (Aerospace), a national nonprofit operating the only federally funded research and development ...

PRNewswire New Delhi [India] January 24 Attentiveai a leading AI-based SaaS startup today announced the successful close of its Series A2 funding round completing a 12M raise in Series A in two tranch ...

Despite the economic uncertainties, healthcare analytics companies have demonstrated strong resilience throughout 2024. The global healthcare analytics industry market size is estimated to grow from ...

Copyright 2025 The Associated Press. All Rights Reserved. Minnesota forward Dawson Garcia (3) celebrates with teammates after a game-winning 3-point shot at the ...

Garcia’s 3-pointer from the near edge of the center-court logo beat the overtime buzzer to give Minnesota an 84-81 victory over No. 20 Michigan on Thursday night. Garcia, whose two free throws ...

Read on below for takeaways from Notre Dame's win over Penn State. Penn State edge rusher Abdul Carter's status was up in the air ahead of the Orange Bowl. He suffered a left shoulder injury in ...

Sam Vecenie of The Athletic reported Sunday that Memphis "is in the market for a big wing with a defensive edge." With that as the backdrop, Vecenie called the Grizzlies his "favorite wild-card ...

Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s shares closed yesterday at $53.20. Discover the latest ...